Company Filing History:
Years Active: 2025
Title: Joanna Jaszczewska-Adamczak: Innovator in Therapeutic Agents
Introduction
Joanna Jaszczewska-Adamczak is a prominent inventor based in Warsaw, Poland. She has made significant contributions to the field of therapeutic agents, particularly in the development of compounds that activate TP53, a crucial protein in cancer prevention and treatment.
Latest Patents
Joanna holds a patent for her invention titled "1,2,3',5'-tetrahydro-2'h-spiro[indole-3,1'-pyrrolo[3,4-C]pyrrole]-2,3'-dione compounds as therapeutic agents activating TP53." This invention relates to compounds represented by a specific formula, which can be utilized in the prevention and treatment of various diseases, including cancer, immune diseases, inflammatory conditions, and viral infections. She has 1 patent to her name.
Career Highlights
Joanna is currently employed at Adamed Pharma S.A., where she continues to innovate and contribute to the pharmaceutical industry. Her work focuses on developing new therapeutic solutions that can significantly impact patient care and treatment outcomes.
Collaborations
Joanna collaborates with talented professionals in her field, including Marcin Feder and Maria Mazur. Their combined expertise enhances the research and development efforts at Adamed Pharma S.A.
Conclusion
Joanna Jaszczewska-Adamczak is a dedicated inventor whose work in therapeutic agents showcases her commitment to advancing medical science. Her innovative contributions have the potential to improve treatment options for various diseases, making her a valuable asset in the field of pharmaceuticals.